Crinetics Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. 

CEO
Scott R. Struthers
CEOScott R. Struthers
Employees
143
Employees143
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2008
Founded2008
Employees
143
Employees143

CRNX Key Statistics

Market cap
1.06B
Market cap1.06B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
215.03K
Average volume215.03K
High today
$20.57
High today$20.57
Low today
$19.30
Low today$19.30
Open price
$19.30
Open price$19.30
Volume
199.80K
Volume199.80K
52 Week high
$28.95
52 Week high$28.95
52 Week low
$15.91
52 Week low$15.91

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

CRNX Earnings

-$0.81
-$0.54
-$0.27
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.